Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rank in Stocks #28154
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.40
Last synced: 2026-08-18
Market Cap
$28.25M
Change (1 day)
0.00%
Change (1 year)
536.36%
Country
IL
Trade Raphael Pharmaceutical Inc. (RAPH)

Category

Number of shares outstanding for Raphael Pharmaceutical Inc. (RAPH)
Number of shares outstanding as of August 2026: 0
According to Raphael Pharmaceutical Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Raphael Pharmaceutical Inc. (RAPH) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors